Terms: = Breast cancer AND NCOR1, hCIT529I10, 9611, ENSG00000141027, N-CoR, MGC104216, TRAC1, O75376, hN-CoR, KIAA1047 AND Treatment
31 results:
1. Estrone, the major postmenopausal estrogen, binds ERa to induce SNAI2, epithelial-to-mesenchymal transition, and ER+ breast cancer metastasis.
Qureshi R; Picon-Ruiz M; Sho M; Van Booven D; Nunes de Paiva V; Diaz-Ruano AB; Ince TA; Slingerland J
Cell Rep; 2022 Nov; 41(7):111672. PubMed ID: 36384125
[TBL] [Abstract] [Full Text] [Related]
2. FOXF2 oppositely regulates stemness in luminal and basal-like breast cancer cells through the Wnt/beta-catenin pathway.
Zhang X; Zhang R; Hou C; He R; Wang QS; Zhou TH; Li XQ; Zhai QL; Feng YM
J Biol Chem; 2022 Jul; 298(7):102082. PubMed ID: 35660418
[TBL] [Abstract] [Full Text] [Related]
3. Design, synthesis, biological evaluation, QSAR analysis and molecular modelling of new thiazol-benzimidazoles as EGFR inhibitors.
Srour AM; Ahmed NS; Abd El-Karim SS; Anwar MM; El-Hallouty SM
Bioorg Med Chem; 2020 Sep; 28(18):115657. PubMed ID: 32828424
[TBL] [Abstract] [Full Text] [Related]
4. Exposure-response analysis of endoxifen serum concentrations in early-breast cancer.
Sanchez-Spitman AB; Moes DAR; Swen JJ; Dezentjé VO; Lambrechts D; Neven P; Gelderblom H; Guchelaar HJ
Cancer Chemother Pharmacol; 2020 Jun; 85(6):1141-1152. PubMed ID: 32468081
[TBL] [Abstract] [Full Text] [Related]
5. Norcantharidin regulates ERα signaling and tamoxifen resistance via targeting miR-873/CDK3 in breast cancer cells.
Zhang X; Zhang B; Zhang P; Lian L; Li L; Qiu Z; Qian K; Chen A; Liu Q; Jiang Y; Cui J; Qi B
PLoS One; 2019; 14(5):e0217181. PubMed ID: 31120927
[TBL] [Abstract] [Full Text] [Related]
6. SNP mutation-related genes in breast cancer for monitoring and prognosis of patients: A study based on the TCGA database.
Gao C; Zhuang J; Zhou C; Li H; Liu C; Liu L; Feng F; Liu R; Sun C
Cancer Med; 2019 May; 8(5):2303-2312. PubMed ID: 30883028
[TBL] [Abstract] [Full Text] [Related]
7. Reciprocal transrepression between FOXF2 and FOXQ1 controls basal-like breast cancer aggressiveness.
Kang LJ; Yu ZH; Cai J; He R; Lu JT; Hou C; Wang QS; Li XQ; Zhang R; Feng YM
FASEB J; 2019 May; 33(5):6564-6573. PubMed ID: 30807702
[TBL] [Abstract] [Full Text] [Related]
8. Molecular profiling of hormone receptor-positive, HER2-negative breast cancers from patients treated with neoadjuvant endocrine therapy in the CARMINA 02 trial (UCBG-0609).
Liang X; Briaux A; Becette V; Benoist C; Boulai A; Chemlali W; Schnitzler A; Baulande S; Rivera S; Mouret-Reynier MA; Bouvet LV; De La Motte Rouge T; Lemonnier J; Lerebours F; Callens C
J Hematol Oncol; 2018 Oct; 11(1):124. PubMed ID: 30305115
[TBL] [Abstract] [Full Text] [Related]
9. Outdoor air pollution, green space, and cancer incidence in Saxony: a semi-individual cohort study.
Datzmann T; Markevych I; Trautmann F; Heinrich J; Schmitt J; Tesch F
BMC Public Health; 2018 Jun; 18(1):715. PubMed ID: 29884153
[TBL] [Abstract] [Full Text] [Related]
10. KLF17 attenuates estrogen receptor α-mediated signaling by impeding ERα function on chromatin and determines response to endocrine therapy.
Ali A; Ielciu I; Alkreathy HM; Khan AA
Biochim Biophys Acta; 2016 Jul; 1859(7):883-95. PubMed ID: 27107895
[TBL] [Abstract] [Full Text] [Related]
11. Expression profiling of breast cancer patients treated with tamoxifen: prognostic or predictive significance.
Tabarestani S; Ghaderian SM; Rezvani H; Mirfakhraie R
Med Oncol; 2014 Apr; 31(4):896. PubMed ID: 24563328
[TBL] [Abstract] [Full Text] [Related]
12. Tasquinimod Is an Allosteric Modulator of HDAC4 survival signaling within the compromised cancer microenvironment.
Isaacs JT; Antony L; Dalrymple SL; Brennen WN; Gerber S; Hammers H; Wissing M; Kachhap S; Luo J; Xing L; Björk P; Olsson A; Björk A; Leanderson T
Cancer Res; 2013 Feb; 73(4):1386-99. PubMed ID: 23149916
[TBL] [Abstract] [Full Text] [Related]
13. Cross-talk between HER2 and MED1 regulates tamoxifen resistance of human breast cancer cells.
Cui J; Germer K; Wu T; Wang J; Luo J; Wang SC; Wang Q; Zhang X
Cancer Res; 2012 Nov; 72(21):5625-34. PubMed ID: 22964581
[TBL] [Abstract] [Full Text] [Related]
14. Nuclear corepressor 1 expression predicts response to first-line endocrine therapy for breast cancer patients on relapse.
Zhang ZH; Yamashita H; Toyama T; Yamamoto Y; Kawasoe T; Ibusuki M; Tomita S; Sugiura H; Kobayashi S; Fujii Y; Iwase H
Chin Med J (Engl); 2009 Aug; 122(15):1764-8. PubMed ID: 19781322
[TBL] [Abstract] [Full Text] [Related]
15. Screening and association testing of common coding variation in steroid hormone receptor co-activator and co-repressor genes in relation to breast cancer risk: the Multiethnic Cohort.
Haiman CA; Garcia RR; Hsu C; Xia L; Ha H; Sheng X; Le Marchand L; Kolonel LN; Henderson BE; Stallcup MR; Greene GL; Press MF
BMC Cancer; 2009 Jan; 9():43. PubMed ID: 19183483
[TBL] [Abstract] [Full Text] [Related]
16. ERalpha suppresses slug expression directly by transcriptional repression.
Ye Y; Xiao Y; Wang W; Yearsley K; Gao JX; Barsky SH
Biochem J; 2008 Dec; 416(2):179-87. PubMed ID: 18588516
[TBL] [Abstract] [Full Text] [Related]
17. Electromagnetic fields alter the expression of estrogen receptor cofactors in breast cancer cells.
Girgert R; Gründker C; Emons G; Hanf V
Bioelectromagnetics; 2008 Apr; 29(3):169-76. PubMed ID: 18027843
[TBL] [Abstract] [Full Text] [Related]
18. Overexpression of ER and VDR is not sufficient to make ER-negative MDA-MB231 breast cancer cells responsive to 1alpha-hydroxyvitamin D5.
Peng X; Jhaveri P; Hussain-Hakimjee EA; Mehta RG
Carcinogenesis; 2007 May; 28(5):1000-7. PubMed ID: 17130524
[TBL] [Abstract] [Full Text] [Related]
19. Estrogen-occupied estrogen receptor represses cyclin G2 gene expression and recruits a repressor complex at the cyclin G2 promoter.
Stossi F; Likhite VS; Katzenellenbogen JA; Katzenellenbogen BS
J Biol Chem; 2006 Jun; 281(24):16272-8. PubMed ID: 16608856
[TBL] [Abstract] [Full Text] [Related]
20. Steroid hormone receptors and coregulators in endocrine-resistant and estrogen-independent breast cancer cells.
Sarvilinna N; Eronen H; Miettinen S; Vienonen A; Ylikomi T
Int J Cancer; 2006 Feb; 118(4):832-40. PubMed ID: 16152593
[TBL] [Abstract] [Full Text] [Related]
[Next]
